Redwood City, California-based Pulmonx Corporation, a provider of diagnostic and therapeutic pulmonary device technologies, has raised $65 million in financing. Ally Bridge Group led the round with participation from other investors that included RTW Investments, ArrowMark Partners and Driehaus Capital Management. In addition to the funding, Pulmonx has appointed Dr. Derrick Sung as its chief financial officer.
Source: Press Release